Departamento de Salud
Centro
Ikerbasque, Fundación Vasca para la Ciencia
Bilbao, EspañaPublicaciones en colaboración con investigadores/as de Ikerbasque, Fundación Vasca para la Ciencia (8)
2024
-
Cost-Effectiveness Analysis of Vaccines for COVID-19 According to Sex, Comorbidity and Socioeconomic Status: A Population Study
PharmacoEconomics, Vol. 42, Núm. 2, pp. 219-229
2023
-
The effect of mixed vaccination rollout strategy: A modelling study
Infectious Disease Modelling, Vol. 8, Núm. 2, pp. 318-340
2022
-
Changes in Social and Clinical Determinants of COVID-19 Outcomes Achieved by the Vaccination Program: A Nationwide Cohort Study
International Journal of Environmental Research and Public Health, Vol. 19, Núm. 19
2020
-
A novel Schmallenberg virus subunit vaccine candidate protects IFNAR-/- mice against virulent SBV challenge
Scientific Reports, Vol. 10, Núm. 1
-
Modelling COVID 19 in the Basque Country from introduction to control measure response
Scientific Reports, Vol. 10, Núm. 1
-
Reproduction ratio and growth rates: Measures for an unfolding pandemic
PLoS ONE, Vol. 15, Núm. 7 July
-
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study
International Journal of Cancer, Vol. 147, Núm. 5, pp. 1315-1324
2017
-
DNA vaccination regimes against Schmallenberg virus infection in IFNAR−/− mice suggest two targets for immunization
Antiviral Research, Vol. 141, pp. 107-115